According to a new report by Polaris Market Research, the global leprosy treatment market was valued at USD 3,321.60 million in 2023 and is projected to reach USD 5,000.33 million by 2032, expanding at a CAGR of 4.6% over the forecast period. Growth is underpinned by rising regulatory product approvals, expanding government eradication initiatives, and favorable reimbursement policies...